Last reviewed · How we verify
Breztri Aerosphere
At a glance
| Generic name | Breztri Aerosphere |
|---|---|
| Sponsor | Jianxing He |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease (PHASE4)
- Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness (PHASE1, PHASE2)
- IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US (PHASE4)
- Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy (NA)
- The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Breztri Aerosphere CI brief — competitive landscape report
- Breztri Aerosphere updates RSS · CI watch RSS
- Jianxing He portfolio CI